FORA Capital LLC Acquires Shares of 7,173 Cardinal Health, Inc. $CAH

Key Points

• FORA Capital LLC has made a new investment in Cardinal Health, Inc. amounting to $988,000, purchasing 7,173 shares during the first quarter.
• Several large investors have increased their stakes in Cardinal Health, with JPMorgan Chase & Co. raising its stake by 40% and Wellington Management Group LLP increasing its position by an impressive 1,666.7%.
• Analysts' consensus rating for Cardinal Health is a "Moderate Buy" with an average price target of $165.93, reflecting optimistic expectations among equity research analysts.

FORA Capital LLC acquired a new stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 7,173 shares of the company's stock, valued at approximately $988,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Integrated Wealth Concepts LLC boosted its stake in Cardinal Health by 22.4% in the fourth quarter. Integrated Wealth Concepts LLC now owns 4,083 shares of the company's stock valued at $483,000 after acquiring an additional 748 shares in the last quarter. Northern Trust Corp boosted its stake in Cardinal Health by 16.2% in the fourth quarter. Northern Trust Corp now owns 3,037,849 shares of the company's stock valued at $359,286,000 after acquiring an additional 422,755 shares in the last quarter. Lido Advisors LLC boosted its stake in Cardinal Health by 53.3% in the fourth quarter. Lido Advisors LLC now owns 20,252 shares of the company's stock valued at $2,395,000 after acquiring an additional 7,042 shares in the last quarter. Schonfeld Strategic Advisors LLC boosted its stake in Cardinal Health by 134.9% in the fourth quarter. Schonfeld Strategic Advisors LLC now owns 121,935 shares of the company's stock valued at $14,421,000 after acquiring an additional 70,020 shares in the last quarter. Finally, Voleon Capital Management LP acquired a new stake in Cardinal Health in the fourth quarter valued at approximately $10,279,000. 87.17% of the stock is currently owned by institutional investors.

Insider Activity

In other Cardinal Health news, CEO Stephen M. Mason sold 41,575 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $6,187,191.50. Following the completion of the transaction, the chief executive officer owned 26,085 shares of the company's stock, valued at approximately $3,881,969.70. The trade was a 61.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Ola M. Snow sold 28,151 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the completion of the transaction, the insider directly owned 15,431 shares of the company's stock, valued at $2,298,293.14. The trade was a 64.59% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 271,676 shares of company stock valued at $40,489,525 over the last quarter. Insiders own 0.09% of the company's stock.

Cardinal Health Stock Performance

Shares of Cardinal Health stock traded up $1.22 during trading on Tuesday, hitting $150.00. 412,652 shares of the company's stock were exchanged, compared to its average volume of 2,417,652. The business has a 50-day simple moving average of $157.10 and a 200-day simple moving average of $146.46. Cardinal Health, Inc. has a 52-week low of $106.54 and a 52-week high of $168.44. The stock has a market capitalization of $35.82 billion, a price-to-earnings ratio of 23.27, a PEG ratio of 1.26 and a beta of 0.73.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm had revenue of $60.16 billion during the quarter, compared to analysts' expectations of $60.91 billion. During the same quarter last year, the company posted $1.84 earnings per share. The firm's revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, equities analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be issued a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a dividend yield of 1.4%. The ex-dividend date of this dividend is Wednesday, October 1st. Cardinal Health's dividend payout ratio (DPR) is 31.63%.

Analysts Set New Price Targets

Several brokerages have weighed in on CAH. Robert W. Baird raised their target price on shares of Cardinal Health from $197.00 to $203.00 and gave the company an "outperform" rating in a research note on Wednesday, August 13th. Citigroup restated a "neutral" rating and issued a $170.00 target price (up from $157.00) on shares of Cardinal Health in a research note on Friday, June 13th. Jefferies Financial Group set a $150.00 price objective on shares of Cardinal Health in a research note on Tuesday, August 12th. Wall Street Zen downgraded shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 2nd. Finally, Argus set a $189.00 price objective on shares of Cardinal Health in a research note on Friday, August 22nd. Twelve research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, Cardinal Health has an average rating of "Moderate Buy" and a consensus price target of $165.93.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.